About
I am a co-founder and Chief Medical Officer of Strata Oncology, where we are focused on…
Articles by Scott
-
Immunotherapy Response Score: A diagnostic tool for anti-PD-1/PD-L1 treatment decisions
Immunotherapy Response Score: A diagnostic tool for anti-PD-1/PD-L1 treatment decisions
By Scott Tomlins
Activity
-
Look forward to joining Howard Soule and Scott Tomlins for a panel discussion during the Prostate Cancer Foundation Annual Meeting in a week!
Look forward to joining Howard Soule and Scott Tomlins for a panel discussion during the Prostate Cancer Foundation Annual Meeting in a week!
Liked by Scott Tomlins
-
Strata CEO Dan Rhodes sat down with Clinical Lab Products to discuss the promise and challenges facing precision oncology https://lnkd.in/ghX9_euY
Strata CEO Dan Rhodes sat down with Clinical Lab Products to discuss the promise and challenges facing precision oncology https://lnkd.in/ghX9_euY
Liked by Scott Tomlins
Experience
Education
More activity by Scott
-
We are excited to announce $48M in financing from investors F-Prime Capital, OrbiMed, Deerfield Management, Decheng Capital, RA Capital Management…
We are excited to announce $48M in financing from investors F-Prime Capital, OrbiMed, Deerfield Management, Decheng Capital, RA Capital Management…
Liked by Scott Tomlins
-
Strata Oncology is excited to announce new data supporting the utility of Immunotherapy Response Score to guide informed clinical decisions for…
Strata Oncology is excited to announce new data supporting the utility of Immunotherapy Response Score to guide informed clinical decisions for…
Liked by Scott Tomlins
-
Strata Oncology is excited to announce the publication of a new study adding to the clinical utility of our innovative Immunotherapy Response Score…
Strata Oncology is excited to announce the publication of a new study adding to the clinical utility of our innovative Immunotherapy Response Score…
Liked by Scott Tomlins
-
Dr. Sachdev Thomas of Kaiser Permanente spoke with OncLive about the independent validation of Strata's Immunotherapy Response Score that his team…
Dr. Sachdev Thomas of Kaiser Permanente spoke with OncLive about the independent validation of Strata's Immunotherapy Response Score that his team…
Liked by Scott Tomlins
-
Very excited to share the launch of Medicare covered Strata Select for patients with advanced solid tumors. Whether to use immunotherapy, alone or in…
Very excited to share the launch of Medicare covered Strata Select for patients with advanced solid tumors. Whether to use immunotherapy, alone or in…
Shared by Scott Tomlins
-
#Immunotherapy can be a #gamechanger in some cases of advanced #cancer and lead to years of remission or even cures in stage 4 cancer. But not…
#Immunotherapy can be a #gamechanger in some cases of advanced #cancer and lead to years of remission or even cures in stage 4 cancer. But not…
Liked by Scott Tomlins
-
#ICYMI: Last week we published a peer-reviewed study in Communications Medicine validating the clinical utility of our pan-solid tumor predictive…
#ICYMI: Last week we published a peer-reviewed study in Communications Medicine validating the clinical utility of our pan-solid tumor predictive…
Liked by Scott Tomlins
-
Learn how Strata Oncology is discovering, validating and demonstrating clinical utility for multiple new biomarker algorithms in this new article…
Learn how Strata Oncology is discovering, validating and demonstrating clinical utility for multiple new biomarker algorithms in this new article…
Liked by Scott Tomlins
-
Check out the coverage in GenomeWeb of Strata’s recent paper validating the clinical utility of our pan-solid tumor predictive biomarker for…
Check out the coverage in GenomeWeb of Strata’s recent paper validating the clinical utility of our pan-solid tumor predictive biomarker for…
Liked by Scott Tomlins
-
A new study from Strata Oncology validates the clinical utility of a pan-solid tumor #biomarker, IRS (Immunotherapy Response Score), that predicts…
A new study from Strata Oncology validates the clinical utility of a pan-solid tumor #biomarker, IRS (Immunotherapy Response Score), that predicts…
Liked by Scott Tomlins
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Scott Tomlins
3 others named Scott Tomlins are on LinkedIn
See others named Scott Tomlins